Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
QuintilesIMS
McKesson
Chubb
Medtronic
Teva
Baxter
Colorcon
Johnson and Johnson
Fuji

Generated: October 17, 2017

DrugPatentWatch Database Preview

OPTIRAY 300 Drug Profile

« Back to Dashboard

What is the patent landscape for Optiray 300, and what generic Optiray 300 alternatives are available?

Optiray 300 is a drug marketed by Liebel-flarsheim and is included in two NDAs.

The generic ingredient in OPTIRAY 300 is ioversol. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ioversol profile page.

Summary for Tradename: OPTIRAY 300

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list28
Clinical Trials: see list2,257
Patent Applications: see list735
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OPTIRAY 300 at DailyMed

Pharmacology for Tradename: OPTIRAY 300

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim
OPTIRAY 300
ioversol
INJECTABLE;INJECTION019710-004Jan 22, 1992RXYesYes► Subscribe► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 300
ioversol
INJECTABLE;INJECTION020923-004May 13, 1999RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OPTIRAY 300

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Liebel-flarsheim
OPTIRAY 300
ioversol
INJECTABLE;INJECTION019710-004Jan 22, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Queensland Health
Accenture
US Army
Merck
QuintilesIMS
Boehringer Ingelheim
Moodys
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot